Des Ilegbodu
Des Ilegbodu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Breast Cancer Treatment Studies.
- World rank
- #4,036,114 of 7,710,434 ranked researchers
- Rank in United States
- #1,098,952 of 1,627,098
- Works
- 33
- Citations
- 950
- Citations per work
- 28.8
What does Des Ilegbodu research?
Des Ilegbodu's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2678.6%
- Medicine2678.6%
- Everything else514.3%
- Life Sciences27.1%
- 1Oncology39% of their works
- 2Pulmonary and Respiratory Medicine26% of their works
- 3Cancer Research7% of their works
- 4Surgery5% of their works
- 5Hepatology5% of their works
- 6Dermatology3% of their works
Research topics
Which keywords describe Des Ilegbodu's research?
The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chemotherapy, EGFR Mutations, Targeted Therapy, Molecular Subtypes, Clinical Practice Guidelines and Radiotherapy.
- Estrogen
- Lung Cancer
- CT Screening
- Hepatocellular Carcinoma
- Cetuximab
- Breast Tumours
- Radiotherapy
- Molecular Subtypes
- EGFR Mutations
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Chemotherapy
- Targeted Therapy
- Clinical Practice Guidelines
- Breast Cancer
- Gene Expression
- KRAS Mutations
- Liver Cancer
- HER2
- Trastuzumab
- Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy-Induced Peripheral Neuropathy191 topic
- Taxanes191 topic
- Chemotherapy143 topics
- EGFR Mutations141 topic
- Targeted Therapy141 topic
- Molecular Subtypes132 topics
- Clinical Practice Guidelines122 topics
- Radiotherapy112 topics
- Breast Cancer72 topics
- Breast Tumours71 topic
- Gene Expression71 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Hepatocellular Carcinoma51 topic
- Liver Cancer51 topic
- CT Screening41 topic
- HER241 topic
- Lung Cancer41 topic
- Trastuzumab41 topic
- Estrogen31 topic
- Receptor31 topic
Where does Des Ilegbodu work?
Des Ilegbodu's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Des Ilegbodu have?
OpenAlex counts 33 works and 950 citations for Des Ilegbodu, an h-index of 13, ranking #4,036,114 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Des Ilegbodu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.